Table 3.
Genes involved in homeostasis and cell growth, which were found to be significantly up-regulated in PBMCs of SARS patients. Level of expression is expressed in Fold change (average of fold changes of ten patients, S1-S10) as compared to that of control samples from normal human subjects (C1-C4).
| Gen Bank ID | Description | Gene name | Fold change (S1-S10) |
| BC005248.1 | Eukaryotic translation initiation factor 1A | EIF1AY | 44.79 |
| NM_001008.1 | Ribosomal protein S4, Y-linked | RPS4Y | 20.75 |
| NM_001062.1 | transcobalamin I (vitamin B12 binding protein, R binder family) | TCN1 | 16.88 |
| NM_002357.1 | MAX dimerization protein | MAD | 11.88 |
| NM_012387.1 | Peptidyl arginine deiminase, type V | PADI4 | 9.12 |
| NM_000184.1 | Hemoglobin, gamma G | HBG2 | 8.7 |
| NM_000559.1 | Hemoglobin, gamma A | HBG1 | 8.1 |
| NM_004653.1 | SMC (mouse) homolog, Y chromosome | SMCY | 7.07 |
| NM_002934.1 | Ribonuclease, RNase A family, 2 | RNASE2 | 5.99 |
| M60721.1 | Homeo box 1 | HLX1 | 5.85 |
| NM_005178.1 | B-cell CLLlymphoma 3 | BCL3 | 5.11 |
| NM_001964.1 | Early growth response 1 | EGR1 | 4.9 |
| NM_006931.1 | Solute carrier family 2, member 3 | SLC2A3 | 4.89 |
| NM_002863.1 | Phosphorylase, glycogen | PYGL | 4.89 |
| NM_021122.2 | Fatty-acid-Coenzyme A ligase, long-chain 2 | FACL2 | 4.87 |
| L13974.1 | Nuclear factor (erythroid-derived) 2 | NFE2 | 4.77 |
| AI313324 | H2A histone family, member O | HIST2H2AA | 4.48 |
| BC002649.1 | H1 histone family, member 2 | HIST1H1C | 4.44 |
| AF073310.1 | insulin receptor substrate-2 | IRS2 | 4.43 |
| NM_005330.2 | hemoglobin, epsilon 1 | HBE1 | 3.97 |
| AF073890.1 | Cathepsin X precursor | CTSZ | 3.69 |
| AB002559.1 | syntaxin binding protein 2 | STXBP2 | 3.69 |
| NM_017445.1 | H2B histone family, member S | HIST1H2BK | 3.64 |
| NM_003118.1 | Secreted protein, acidic, cysteine-rich (osteonectin) | SPARC | 3.62 |
| AL353759 | Two genes for novel histone 1 | HIST1H2AC | 3.54 |
| NM_003681.1 | Pyridoxal (pyridoxine, vitamin B6) kinase | PDXK | 3.54 |
| BC001886.1 | Ribonucleotide reductase M2 polypeptide | RRM2 | 3.53 |
| AI082078 | Actinin, alpha1 | ACTN1 | 3.42 |
| AF087942.1 | Glycogenin-1L | GYG | 3.39 |
| AL538601 | Sjogren syndrome antigen A2 | SSA2 | 3.36 |
| NM_001805.1 | CCAATenhancer binding protein | CEBPE | 3.26 |
| NM_003528.1 | H2B histone family, member Q | HIST2H2BE | 3.13 |
| BC001906.1 | Similar to metaxin 1 | MTX1 | 3.11 |
| NM_006755.1 | Transaldolase 1 | TALDO1 | 3.07 |
| BC000893.1 | Histone family, member A | HIST1H2BK | 3.06 |
| AL161952.1 | Glutamate-ammonia ligase | GLUL | 2.99 |
| BC002842.1 | H2B histone family, member B | HIST1H2BD | 2.78 |
| NM_004219.2 | Pituitary tumor-transforming 1 | PTTG1 | 2.75 |
| NM_012228.1 | Pilin-like transcription factor | PILB | 2.73 |
| L12711.1 | Transketolase | TKT | 2.68 |
| BE561479 | Glyceraldehyde-3-phosphate dehydrogenase | GAPD | 2.61 |
| NM_012331.2 | Methionine sulfoxide reductase A | MSRA | 2.6 |
| M33197 | Glyceraldehyde-3-phosphate dehydrogenase | GAPD | 2.59 |
| NM_005195.1 | CCAAT enhancer binding protein | CEBPD | 2.57 |
| NM_018840.1 | Putative Rab5-interacting protein | C20orf24 | 2.45 |
| AA314406 | Thyroid Hormone Receptor Associated protein | TRAP95 | 2.44 |
| NM_004832.1 | Glutathione-S-transferase like; glutathione transferase omega | GSTTLp28 | 2.42 |
| NM_013272.2 | Solute carrier family 21 (organic anion transporter) | SLC21A11 | 2.42 |